---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-065274"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2025-07-02T23:59:59+00:00"
generated_at: "2026-05-18T09:38:30.238616+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics shareholders approve reverse stock split authorization at annual meeting

## Summary
- Stockholders authorized a reverse stock split at ratio between 1:2 and 1:20, with board discretion to set ratio within one year.
- Re-elected directors Edward J. Borkowski, Richard Paolone, Eric Corbett, Manpreet Uppal, and Jack Syage.
- Ratified Machias Gini & O'Connell LLP as independent auditor for fiscal year ending December 31, 2025.
- Advisory vote on named executive officer compensation passed with 415,176 for, 77,434 against (excluding broker non-votes).
- All five proposals were approved; broker non-votes totaled 1,328,218 on director elections and advisory compensation vote.

## SEC filing metadata
- accession: 0001104659-25-065274
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2025-07-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465925065274/0001104659-25-065274-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465925065274/tm2519627d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-065274
- JSON: https://secwatch.observer/filing/0001104659-25-065274.json
- Plain text: https://secwatch.observer/filing/0001104659-25-065274.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.